Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001722024-20-000005
Filing Date
2020-06-16
Accepted
2020-06-16 16:38:43
Documents
1
Period of Report
2020-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159233990259960.html 4  
1 FORM 4 wf-form4_159233990259960.xml 4 9605
  Complete submission text file 0001722024-20-000005.txt   11385
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Issuer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 26 NORTH EUCLID AVENUE PASADENA CA 91101
Business Address 26 NORTH EUCLID AVENUE PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39321 | Film No.: 20966864